| PDAC | Pancreatic ductal adenocarcinoma |
| CT | Chemotherapy |
| FOLFNX | FOLFIRINOX |
| GEMPAC | Gemcitabine plus Nab-paclitaxel |
| CTRL | Untreated control |
| mOS | Median overall survival |
| PFS | Progression-free survival |
| OS | Overall survival |
| ECOG PS | Eastern Cooperative Oncology Group Performance Status |
| GO | Gene Ontology |
| IPA | Ingenuity Pathway Analysis |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| TCGA | The Cancer Genome Atlas |
| LC-MS | Liquid Chromatography-Mass Spectrometry |
| POI | Proteins of interest |
| ATCC | American Tissue Culture Collection |
| DMEM | Dulbecco’s Modified Eagle Medium |
| DDA | Data Dependent Acquisition |
| PASEF | Parallel Accumulation-Serial Fragmentation |
| LFQ | Label-free quantification |
| MNAR | Missing not at random |
| PPI | Protein–protein interaction |
| STRING | Search Tool for the Retrieval of Interacting Genes/Proteins |
| MCODE | Molecular Complex Deletion |
| CC | Cellular Component |
| BP | Biological Process |
| MF | Molecular Function |
| PAAD | Pancreatic adenocarcinoma |
| TME | Tumor microenvironment |
| ECM | Extracellular matrix |